1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostate Cancer Medicine Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 LHRH Antagonists
1.2.3 LHRH Analogs
1.2.4 Antiandrogens
1.2.5 Pipeline Drugs for Hormonal Therapy
1.3 Market by Application
1.3.1 Global Prostate Cancer Medicine Market Share by Application: 2018 VS 2022 VS 2029
1.3.2 Age Below 55
1.3.3 Age 55-75
1.3.4 Age Above 75
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Prostate Cancer Medicine Market Perspective (2018-2029)
2.2 Prostate Cancer Medicine Growth Trends by Region
2.2.1 Prostate Cancer Medicine Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Prostate Cancer Medicine Historic Market Size by Region (2018-2023)
2.2.3 Prostate Cancer Medicine Forecasted Market Size by Region (2024-2029)
2.3 Prostate Cancer Medicine Market Dynamics
2.3.1 Prostate Cancer Medicine Industry Trends
2.3.2 Prostate Cancer Medicine Market Drivers
2.3.3 Prostate Cancer Medicine Market Challenges
2.3.4 Prostate Cancer Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prostate Cancer Medicine Players by Revenue
3.1.1 Global Top Prostate Cancer Medicine Players by Revenue (2018-2023)
3.1.2 Global Prostate Cancer Medicine Revenue Market Share by Players (2018-2023)
3.2 Global Prostate Cancer Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Prostate Cancer Medicine Revenue
3.4 Global Prostate Cancer Medicine Market Concentration Ratio
3.4.1 Global Prostate Cancer Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Medicine Revenue in 2022
3.5 Prostate Cancer Medicine Key Players Head office and Area Served
3.6 Key Players Prostate Cancer Medicine Product Solution and Service
3.7 Date of Enter into Prostate Cancer Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Prostate Cancer Medicine Breakdown Data by Type
4.1 Global Prostate Cancer Medicine Historic Market Size by Type (2018-2023)
4.2 Global Prostate Cancer Medicine Forecasted Market Size by Type (2024-2029)
5 Prostate Cancer Medicine Breakdown Data by Application
5.1 Global Prostate Cancer Medicine Historic Market Size by Application (2018-2023)
5.2 Global Prostate Cancer Medicine Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Prostate Cancer Medicine Market Size (2018-2029)
6.2 North America Prostate Cancer Medicine Market Size by Country (2018-2023)
6.3 North America Prostate Cancer Medicine Market Size by Country (2024-2029)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Prostate Cancer Medicine Market Size (2018-2029)
7.2 Europe Prostate Cancer Medicine Market Size by Country (2018-2023)
7.3 Europe Prostate Cancer Medicine Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Prostate Cancer Medicine Market Size (2018-2029)
8.2 Asia-Pacific Prostate Cancer Medicine Market Size by Country (2018-2023)
8.3 Asia-Pacific Prostate Cancer Medicine Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Prostate Cancer Medicine Market Size (2018-2029)
9.2 Latin America Prostate Cancer Medicine Market Size by Country (2018-2023)
9.3 Latin America Prostate Cancer Medicine Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prostate Cancer Medicine Market Size (2018-2029)
10.2 Middle East & Africa Prostate Cancer Medicine Market Size by Country (2018-2023)
10.3 Middle East & Africa Prostate Cancer Medicine Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 AstraZeneca plc
11.1.1 AstraZeneca plc Company Detail
11.1.2 AstraZeneca plc Business Overview
11.1.3 AstraZeneca plc Prostate Cancer Medicine Introduction
11.1.4 AstraZeneca plc Revenue in Prostate Cancer Medicine Business (2018-2023)
11.1.5 AstraZeneca plc Recent Development
11.2 Active Biotech
11.2.1 Active Biotech Company Detail
11.2.2 Active Biotech Business Overview
11.2.3 Active Biotech Prostate Cancer Medicine Introduction
11.2.4 Active Biotech Revenue in Prostate Cancer Medicine Business (2018-2023)
11.2.5 Active Biotech Recent Development
11.3 Bristol Myers-Squibb
11.3.1 Bristol Myers-Squibb Company Detail
11.3.2 Bristol Myers-Squibb Business Overview
11.3.3 Bristol Myers-Squibb Prostate Cancer Medicine Introduction
11.3.4 Bristol Myers-Squibb Revenue in Prostate Cancer Medicine Business (2018-2023)
11.3.5 Bristol Myers-Squibb Recent Development
11.4 Teva Pharmaceuticals Industries Ltd.
11.4.1 Teva Pharmaceuticals Industries Ltd. Company Detail
11.4.2 Teva Pharmaceuticals Industries Ltd. Business Overview
11.4.3 Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Introduction
11.4.4 Teva Pharmaceuticals Industries Ltd. Revenue in Prostate Cancer Medicine Business (2018-2023)
11.4.5 Teva Pharmaceuticals Industries Ltd. Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Detail
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Prostate Cancer Medicine Introduction
11.5.4 Johnson & Johnson Revenue in Prostate Cancer Medicine Business (2018-2023)
11.5.5 Johnson & Johnson Recent Development
11.6 Pfizer Inc.
11.6.1 Pfizer Inc. Company Detail
11.6.2 Pfizer Inc. Business Overview
11.6.3 Pfizer Inc. Prostate Cancer Medicine Introduction
11.6.4 Pfizer Inc. Revenue in Prostate Cancer Medicine Business (2018-2023)
11.6.5 Pfizer Inc. Recent Development
11.7 Bayer AG
11.7.1 Bayer AG Company Detail
11.7.2 Bayer AG Business Overview
11.7.3 Bayer AG Prostate Cancer Medicine Introduction
11.7.4 Bayer AG Revenue in Prostate Cancer Medicine Business (2018-2023)
11.7.5 Bayer AG Recent Development
11.8 Abbott Laboratories
11.8.1 Abbott Laboratories Company Detail
11.8.2 Abbott Laboratories Business Overview
11.8.3 Abbott Laboratories Prostate Cancer Medicine Introduction
11.8.4 Abbott Laboratories Revenue in Prostate Cancer Medicine Business (2018-2023)
11.8.5 Abbott Laboratories Recent Development
11.9 Astellas Pharma Inc.
11.9.1 Astellas Pharma Inc. Company Detail
11.9.2 Astellas Pharma Inc. Business Overview
11.9.3 Astellas Pharma Inc. Prostate Cancer Medicine Introduction
11.9.4 Astellas Pharma Inc. Revenue in Prostate Cancer Medicine Business (2018-2023)
11.9.5 Astellas Pharma Inc. Recent Development
11.10 Roche Holding AG
11.10.1 Roche Holding AG Company Detail
11.10.2 Roche Holding AG Business Overview
11.10.3 Roche Holding AG Prostate Cancer Medicine Introduction
11.10.4 Roche Holding AG Revenue in Prostate Cancer Medicine Business (2018-2023)
11.10.5 Roche Holding AG Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
